PARIS & REDWOOD CITY, Calif.--(BUSINESS WIRE)--Avinger, Inc. released initial data from the CONNECT Study today at the EuroPCR Conference in Paris. The study evaluated the safety and efficacy of the Wildcat Catheter in crossing chronic total occlusions (CTOs) in femoropopliteal lesions, the leading cause of amputation for patients suffering from peripheral artery disease (PAD).
